193 related articles for article (PubMed ID: 10561370)
1. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
[TBL] [Abstract][Full Text] [Related]
2. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.
Franklin S; Pho T; Abreo FW; Nassar R; De Benedetti A; Stucker FJ; Nathan CO
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):177-82. PubMed ID: 10037284
[TBL] [Abstract][Full Text] [Related]
3. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
Nathan CO; Liu L; Li BD; Abreo FW; Nandy I; De Benedetti A
Oncogene; 1997 Jul; 15(5):579-84. PubMed ID: 9247311
[TBL] [Abstract][Full Text] [Related]
4. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.
Nathan CO; Sanders K; Abreo FW; Nassar R; Glass J
Cancer Res; 2000 Jul; 60(13):3599-604. PubMed ID: 10910074
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
6. [The molecular marker eIF4E in the surgical margins of the resection preparations of head-neck tumors as a prognostic factor].
Ernst-Stecken A
Strahlenther Onkol; 2000 Aug; 176(8):383-4. PubMed ID: 10987024
[No Abstract] [Full Text] [Related]
7. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
[TBL] [Abstract][Full Text] [Related]
8. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
Abouhashem NS; Elwan A; Elaidy NF
Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
[TBL] [Abstract][Full Text] [Related]
10. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
13.
Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
Li BD; Gruner JS; Abreo F; Johnson LW; Yu H; Nawas S; McDonald JC; DeBenedetti A
Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
[TBL] [Abstract][Full Text] [Related]
16. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
Sorrells DL; Meschonat C; Black D; Li BD
J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
[TBL] [Abstract][Full Text] [Related]
17. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma.
Singh J; Jayaraj R; Baxi S; Mileva M; Skinner J; Dhand NK; Thomas M
Mol Clin Oncol; 2016 Feb; 4(2):166-172. PubMed ID: 26893854
[TBL] [Abstract][Full Text] [Related]
19. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
